Sastasundar Ventures Limited (SASTASUNDR.BO)
INR 262.85
(-1.92%)
INR 262.85
(-1.92%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.5 Billion INR | -29.3% |
| 2022 | 2.12 Billion INR | 15.63% |
| 2021 | 1.83 Billion INR | 189.39% |
| 2020 | 634.32 Million INR | -8.46% |
| 2019 | 692.91 Million INR | 130.15% |
| 2018 | 301.07 Million INR | -13.11% |
| 2017 | 346.48 Million INR | -37.72% |
| 2016 | 556.31 Million INR | 46.47% |
| 2015 | 379.8 Million INR | 44.98% |
| 2014 | 261.97 Million INR | -32.12% |
| 2013 | 385.94 Million INR | 0.11% |
| 2012 | 385.53 Million INR | -22.24% |
| 2011 | 495.79 Million INR | 59.06% |
| 2010 | 311.7 Million INR | 409.62% |
| 2009 | 61.16 Million INR | 182.41% |
| 2008 | 21.65 Million INR | -86.02% |
| 2007 | 154.92 Million INR | 1525.39% |
| 2006 | 9.53 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | 1.5 Billion INR | 0.0% |
| 2023 FY | 1.5 Billion INR | -29.3% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 2.09 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 2.12 Billion INR | 15.63% |
| 2022 Q2 | 826.14 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 2.12 Billion INR | 0.0% |
| 2021 Q2 | 842.43 Million INR | 0.0% |
| 2021 FY | 1.83 Billion INR | 189.39% |
| 2021 Q4 | 1.83 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 634.32 Million INR | -8.46% |
| 2020 Q4 | 634.32 Million INR | 0.0% |
| 2020 Q2 | 487.28 Million INR | 0.0% |
| 2019 Q4 | 692.91 Million INR | 0.0% |
| 2019 Q2 | 589.08 Million INR | 0.0% |
| 2019 FY | 692.91 Million INR | 130.15% |
| 2018 Q4 | 301.07 Million INR | 0.0% |
| 2018 FY | 301.07 Million INR | -13.11% |
| 2018 Q2 | 404.24 Million INR | 0.0% |
| 2017 Q2 | 349.68 Million INR | 0.0% |
| 2017 Q4 | 346.48 Million INR | 0.0% |
| 2017 FY | 346.48 Million INR | -37.72% |
| 2016 Q4 | 556.31 Million INR | 0.0% |
| 2016 FY | 556.31 Million INR | 46.47% |
| 2015 Q2 | 322.89 Million INR | 0.0% |
| 2015 Q4 | 379.8 Million INR | 0.0% |
| 2015 FY | 379.8 Million INR | 44.98% |
| 2014 Q4 | 261.97 Million INR | 0.0% |
| 2014 FY | 261.97 Million INR | -32.12% |
| 2014 Q2 | 362.15 Million INR | 0.0% |
| 2013 Q4 | 385.94 Million INR | 0.0% |
| 2013 Q2 | 313.6 Million INR | 0.0% |
| 2013 FY | 385.94 Million INR | 0.11% |
| 2012 Q4 | 385.53 Million INR | 0.0% |
| 2012 Q2 | 2.54 Billion INR | 0.0% |
| 2012 FY | 385.53 Million INR | -22.24% |
| 2011 FY | 495.79 Million INR | 59.06% |
| 2010 FY | 311.7 Million INR | 409.62% |
| 2009 FY | 61.16 Million INR | 182.41% |
| 2008 FY | 21.65 Million INR | -86.02% |
| 2007 FY | 154.92 Million INR | 1525.39% |
| 2006 FY | 9.53 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| ANG Lifesciences India Limited | 1.66 Billion INR | 9.69% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -842.557% |
| Bacil Pharma Limited | 1.12 Million INR | -132813.02% |
| BDH Industries Limited | 312.53 Million INR | -380.134% |
| Beryl Drugs Limited | 85.63 Million INR | -1652.286% |
| Cian Healthcare Limited | 1.03 Billion INR | -45.075% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -70416.353% |
| Colinz Laboratories Limited | 24.1 Million INR | -6125.215% |
| Concord Drugs Limited | 249.88 Million INR | -500.509% |
| Deccan Health Care Limited | 111.33 Million INR | -1247.801% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -1174.655% |
| Denis Chem Lab Limited | 289.82 Million INR | -417.762% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -828.157% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -660.28% |
| Hindustan Bio Sciences Limited | 25.7 Million INR | -5738.622% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 12.566% |
| Makers Laboratories Limited | 569.18 Million INR | -163.64% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -16813.751% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -644.369% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | -50.608% |
| Medi-Caps Limited | 63.01 Million INR | -2281.281% |
| MedPlus Health Services Limited | 14.27 Billion INR | 89.488% |
| Panchsheel Organics Limited | 340.2 Million INR | -341.087% |
| Parmax Pharma Limited | 117.56 Million INR | -1176.361% |
| Parnax Lab Limited | 1.17 Billion INR | -28.177% |
| Patidar Buildcon Limited | 25.57 Million INR | -5768.09% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -501768.896% |
| Smruthi Organics Limited | 485.72 Million INR | -208.941% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -3475.212% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 12.461% |
| Trident Lifeline Limited | 331.26 Million INR | -352.991% |
| Transchem Limited | 6.72 Million INR | -22230.179% |
| Trinity League India Limited | 876 Thousand INR | -171200.0% |
| Tyche Industries Limited | 101.64 Million INR | -1376.361% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -414.824% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -756.661% |
| Vivanza Biosciences Limited | 148.63 Million INR | -909.606% |
| Zenith Healthcare Limited | 24.03 Million INR | -6143.345% |
| Zenlabs Ethica Limited | 301.35 Million INR | -397.949% |
| Phaarmasia Limited | 211.49 Million INR | -609.515% |
| PRAVEG LIMITED | 767.53 Million INR | -95.507% |
| Sunil Healthcare Limited | 902.83 Million INR | -66.209% |
| Syschem (India) Limited | 1.07 Billion INR | -40.148% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -867.715% |
| Mercury Laboratories Limited | 171.18 Million INR | -776.568% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -7049.061% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -2697.152% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | -49.412% |
| Roopa Industries Limited | 493.08 Million INR | -204.325% |
| PANJON LTD. | 25.38 Million INR | -5811.783% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -619.91% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -9917.945% |
| Anuh Pharma Limited | 1.54 Billion INR | 2.851% |
| Crestchem Limited | 23.94 Million INR | -6166.288% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -11094.241% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -1169.286% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 19.379% |
| Trimurthi Limited | 101.36 Thousand INR | -1480353.828% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -642.961% |
| Norris Medicines Limited | 278.17 Million INR | -439.444% |
| Veerhealth Care Limited | 62.78 Million INR | -2290.233% |
| Lactose (India) Limited | 536.39 Million INR | -179.753% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -80.111% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | -32.69% |
| Gennex Laboratories Limited | 535.21 Million INR | -180.373% |
| Godavari Drugs Limited | 957.86 Million INR | -56.66% |
| Zenotech Laboratories Limited | 156.64 Million INR | -857.936% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -207.266% |
| Bharat Parenterals Limited | 2.65 Billion INR | 43.512% |
| Coral Laboratories Limited | 281.83 Million INR | -432.427% |
| Evoq Remedies Limited | 116.23 Million INR | -1191.028% |
| Kerala Ayurveda Limited | 1.05 Billion INR | -41.88% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 26.551% |
| Natural Capsules Limited | 1.47 Billion INR | -1.583% |
| Auro Laboratories Limited | 433.09 Million INR | -246.479% |